Tag Archives: biotechnology news

Patent Reform Bills – Grace Period A Mixed Blessing

Hal Wegner writes to summarize the “holes” in the grace period for activities by the inventor, as present in both bills. If you support these reform bills, at least be sure you know what you and your clients will be … Continue reading

Posted in Patent Reform Legislation | Tagged , , , , , , , , , , | Leave a comment

PTO Issues Final Rule to Implement Prioritized Examination Track (Track I)

The following is from the Schwegman, Lundberg & Woessner Newsletter, April 6, 2011. The Patent and Trademark Office on April 4, 2011, issued a final rule to implement prioritized examination upon an applicant’s request and payment of a $4,000 request … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , , | Leave a comment

Federal Court Hears Myriad Gene Case This Morning

The following is a guest post from Ann McCrackin. I attended oral arguments at the CAFC on Monday for Association for Molecular Pathology v. Myriad Genetics, Inc.   The three-judge panel included Judge Bryson, Judge Lourie and Judge Moore.  Most of the … Continue reading

Posted in Burden of Proof | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Banning Stem Cell Research — Or Cloning? Or Both?

A front-page article in the Minneapolis StarTribune entitled “Stakes High In Cloning Debate” (March 30, 2011) discusses a bill recently introduced into the Minnesota legislature to criminalize “human cloning.” The article reflects on the confusion surrounding what it is, exactly, that groups … Continue reading

Posted in Stem Cells/Cloning | Tagged , , , , , , , , , , , | Leave a comment